SOURCE: StockCall

StockCall

August 12, 2011 09:11 ET

Equity Research on CVS Caremark Corporation and Walgreen Co. - Some Drug Stores Seeing Higher Revenues

JOHANNESBURG, SOUTH AFRICA--(Marketwire - Aug 12, 2011) - www.stockcall.com/ offers investors comprehensive research on the Drug Stores industry and has completed analytical research on CVS Caremark Corporation (NYSE: CVS) and Walgreen Co. (NYSE: WAG). Register with us today at www.stockcall.com/ to have free access to these researches.

Some companies in the Drug Stores sector are seeing higher revenues lately. Recent generics coming to market seem to be one reason the sector is selling more drugs. The problem with generics is that they actually lower revenue due to their lower costs. They are ultimately more profitable though. Revenue increases are instead coming from bigger basket-size and front of the store sales. Register now at https://stockcall.com/development/stockcall/page.php?name=register.html to have free access to our reports on the Drug Stores industry.

www.stockcall.com/ is an online platform where investors doing their due-diligence on the Drug Stores industry can have easy and free access to our analyst research and opinions on CVS Caremark Corporation and Walgreen Co.; investors and shareholders of these companies can simply register for a complimentary membership at https://stockcall.com/development/stockcall/page.php?name=register.html.

While consumers are currently negatively impacted by high unemployment and fuel prices, many companies saw their same-store sales improve in both pharmacy and front-of-the-store segments. CVS Caremark Corporation saw its same store sales grow 2.6%, helping revenue grow 11% to $26.6 billion in the second quarter. CVS Caremark Corporation research report is accessible for free by registering today at www.stockcall.com/CVS120811.pdf.

Similarly, Walgreen Co. saw its same store sales grow in July by 2.7%. Walgreen saw front of the store sales grow 4.8% in the same month. The company is facing potential headwinds relating to its current contract dispute with Express Scripts which could complicate its prescription medicine business. Walgreen Co. research report is available for free by signing up now at www.stockcall.com/WAG120811.pdf.

Visit www.stockcall.com/ to see how companies in this industry have grown over the past years and how they are expected to perform in the future.

About StockCall.com
StockCall.com is a financial website where investors can have easy, precise and comprehensive research and opinions on stocks making the headlines.

Contact Information